Clinical implications of prostaglandin and thromboxane A2 formation (1).
about
The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease.The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the ratReproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor.Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.Internalization and sequestration of the human prostacyclin receptor.Mefenamic Acid induced nephrotoxicity: an animal modelNovel approaches for the prevention of restenosis.Peroxisome Proliferator-Activated Receptors Protect against Apoptosis via 14-3-3.The Zone Diet phenomenon: a closer look at the science behind the claims.Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.Cyclooxygenase inhibitors: any reservations?Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.Understanding the role of prostaglandin E2 in regulating human platelet activity in health and diseaseProstaglandins, masculinization and its disorders: effects of fetal exposure of the rat to the cyclooxygenase inhibitor- indomethacin.Effect of cytoplasmic pH on Ca(2+)-stimulated eicosanoid biosynthesis in human platelets.Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.Dental management considerations for the patient with an acquired coagulopathy. Part 2: Coagulopathies from drugs.Incidence and clinical relevance of heterotopic ossification after internal fixation of acetabular fractures: retrospective cohort and case control study.The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophilsProstanoids and blood pressure: which way is up?The human platelet fibrinogen receptor: clinical and therapeutic significance.Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination.Effect of interleukin 2 on urinary excretion of degradation products of prostacyclin and thromboxane A2 in patients with ovarian cancer.Nonsteroidal anti-inflammatory drugs alter vasa recta diameter via pericytes.Modulation of sensitivity to cis-diamminedichloroplatinum (II) by thromboxane A2 receptor antagonists in non-small-cell lung cancer cell lines.Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).Phase Ib Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Patients with Barrett's Esophagus.Physical (in)activity and endothelium-derived constricting factors: overlooked adaptations.Nonsteroidal anti-inflammatory drugs: effects on kidney function.Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2Electrolyte and Acid-base disturbances associated with non-steroidal anti-inflammatory drugs.Lipid analogues as potential drugs for the regulation of mitochondrial cell death.Platelets and fibrinolysis.Polyunsaturates, endogenous eicosanoids, and cardiovascular disease.The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells.Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a review of the literature.The Syndrome of Veno-occlusive Disease After Blood or Marrow Transplantation.Neutrophil-Derived Cytosolic PLA2α Contributes to Bacterial-Induced Neutrophil Transepithelial Migration.Homologous desensitization of signalling by the alpha (alpha) isoform of the human thromboxane A2 receptor: a specific role for nitric oxide signalling.Differential mapping of the amino acids mediating agonist and antagonist coordination with the human thromboxane A2 receptor protein.
P2860
Q33337940-BA91377C-B95C-463E-A265-123B32575D9BQ33343457-40426701-1937-44FF-94DB-44A8E1F7DB55Q33852848-E8757CDA-B811-4EF5-BA74-EF8357FEF9BFQ33908644-799314A9-F2B2-4158-A3AA-67B196D3A81AQ33908973-747DE062-770A-4523-86BB-B44DF651010DQ34063879-198888B5-05C0-4E2B-9E1C-2F75D4B59B8AQ34075160-7E7F55D0-07F1-40BE-B27F-5C0DDCF3401AQ34123741-0A069AA1-5200-47D1-BF32-B3F004F2EB01Q34175254-594660C5-F5D9-4D44-B0E9-7222EA9E9885Q34247910-9F854EBE-DBC2-4BFE-AF7C-4B66BC592635Q34322409-03D4077C-451B-4B92-A5FE-2B8EB4E23C27Q34395823-EC564AFA-368B-47A2-960C-2DAAC4C8CED2Q34480894-A70A1FE4-0483-4478-9631-4C325E2D00F6Q34720655-178F0E3B-E028-4639-8193-A27282357053Q34793406-DA678FBC-C4E5-4B3D-A5AB-341F2D9A9AD6Q35163045-98F51042-7E30-4EDC-A813-D53A12D5D2B6Q35581058-CE09761F-4596-4539-BDEA-EBAD58826735Q35599637-F3C16C12-0438-4C8E-AA09-8A7066F59A70Q35802504-80640729-E687-411E-8CCF-BE50F9F91B83Q35889642-F56673D1-EF91-488B-A600-BB3248278CA2Q35898379-E9B3E048-5539-4795-8778-A8772A4972D4Q36053867-AE43F0A1-2AE1-406A-8C91-1A4A4B76D5CAQ36081592-871F1172-696E-4596-B75F-99B9326B0010Q36122786-9919D132-6A78-4849-8622-374C0F0EDD98Q36136501-6124777C-0E23-47A8-911F-1CFB1AE72A22Q36248969-CB1FC09B-4217-4983-A6C5-4200887DAF3CQ36349535-5EDEEE7F-63F5-4C73-985E-8F0A3E81755DQ36982237-6B8FCD4E-8516-4338-B5F3-7AD7E57CDAABQ37306896-9593E74C-50F0-4D03-AA2D-9D2A15EEF6E9Q37388131-E15B7718-A1B7-46B3-B0E2-8C42D1278252Q37489103-5F6D45B1-8758-48A3-A33E-47188AEC10A4Q37686274-A1097B7F-8CD2-4099-B408-AD00A49F8C21Q37806238-D8FE2AB2-B240-45DA-9144-6C19BA9DFCA9Q37962272-DDE52035-AF78-4BAF-8A74-D3C8CD6A2076Q38330500-9E736492-05BD-4777-ACA6-93F43095AF80Q38540846-BBFA33F6-E8C2-469A-9518-440CD40D22B4Q38896186-85E77BED-9B5D-4C10-86AB-158CB2C1B0D9Q40059650-00174F57-134B-443D-874F-398D08070C5DQ40139729-ADDD34DD-40C9-4CEF-B62A-6BB0D0398B08Q40256331-13C49051-173C-48EB-9E03-17878D0FD468
P2860
Clinical implications of prostaglandin and thromboxane A2 formation (1).
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Clinical implications of prostaglandin and thromboxane A2 formation (1).
@en
type
label
Clinical implications of prostaglandin and thromboxane A2 formation (1).
@en
prefLabel
Clinical implications of prostaglandin and thromboxane A2 formation (1).
@en
P2093
P1476
Clinical implications of prostaglandin and thromboxane A2 formation (1).
@en
P2093
FitzGerald GA
Jackson EK
Roberts LJ 2nd
P304
P356
10.1056/NEJM198809153191106
P407
P577
1988-09-01T00:00:00Z